INMB
INmune Bio Inc
2.30$
+6.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
INmune Bio Inc (INMB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | -0.3 | -0.8 | -2.1 | -5.4 | -8.9 | -29 | -23 | -12 | -33 | -23 | |
| – | – | – | – | – | – | 0.1 | 0.2 | 0.2 | 0.0 | 0.1 | |
| 0.1 | – | 0.2 | 10 | 4.1 | 3.1 | 4.8 | 7.1 | 7.4 | 7.6 | 9.9 | |
| 0.1 | 0.1 | 0.0 | 10 | 4.1 | 3.1 | 4.8 | 7.1 | – | – | – | |
| 0.0 | -0.1 | 0.0 | 0.4 | -0.3 | 0.0 | -3.1 | -2.9 | 10 | 1.0 | -2.5 | |
| 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 15 | 0.0 | 0.0 | 0.0 | 1.0 | |
| -0.1 | -0.1 | -0.1 | -15 | -15 | -15 | -15 | – | – | – | -1.0 | |
| 0.0 | 0.1 | 2.1 | 0.9 | 12 | -1.0 | 81 | 0.0 | – | – | – | |
| 0.4 | 0.4 | – | 15 | 15 | 15 | 15 | 0.0 | -5.0 | -10 | 0.0 | |
| 0.0 | 0.5 | 2.1 | 0.9 | 12 | 24 | 96 | 0.7 | -4.2 | 18 | 28 | |
| 0.0 | 0.1 | 1.2 | -1.2 | 6.8 | 15 | 53 | -23 | -16 | -15 | 3.8 | |
| 0.0 | -0.3 | -0.9 | -2.1 | -5.4 | -8.9 | -44 | -23 | -12 | -33 | -24 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.